{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:38:21Z","timestamp":1790865501914,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jgyn.2011.05.009","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T18:06:58Z","timestamp":1309975618000},"page":"492-497","source":"Crossref","is-referenced-by-count":1,"title":["M\u00e9dicaments anti-TNF\u03b1 (tumor necrosis factor \u03b1) en gyn\u00e9cologie et en obst\u00e9trique"],"prefix":"10.1016","volume":"40","author":[{"given":"G.","family":"Ducarme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Amate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Seirafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-F.","family":"Ceccaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bouhnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Luton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2011.05.009_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.revmed.2008.04.022","article-title":"Faut-il avoir peur des anti-TNF\u03b1 en 2008\u00a0?","volume":"29","author":"Gaudin","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jri.2010.01.007","article-title":"Anti-TNF\u03b1 therapy in immune-mediated subfertility: state of the art","volume":"85","author":"Clark","year":"2010","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ajg.2009.532","article-title":"Use of infliximab in pregnancy","volume":"105","author":"Mahadevan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/138945010790309885","article-title":"Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review","volume":"11","author":"El Mourabet","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/17474124.2.2.163","article-title":"Efficacy and safety of adalimumab for the treatment of Crohn's disease in adults","volume":"2","author":"Colombel","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eci.09.48","article-title":"Certolizumab pegol for the treatment of Crohn's disease","volume":"5","author":"Baker","year":"2009","journal-title":"Expert Clin Immunol Rev"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","article-title":"PRECISE 1\u00a0study investigators. Certolizumab pegol for the treatment of Crohn's disease","volume":"357","author":"Sandborn","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/ard.2009.126573","article-title":"Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA","volume":"69","author":"Nam","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0045","first-page":"CD007649","article-title":"Certolizumab pegol (CDP870) for rheumatoid arthritis in adults","volume":"2","author":"Ruiz Garcia","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/eci.10.67","article-title":"Rapid and fastforward trials: certolizumab pegol for rheumatoid arthritis","volume":"6","author":"Ramiro","year":"2010","journal-title":"Expert Clin Immunol Rev"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0055","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1476-5381.2010.00702.x","article-title":"Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents","volume":"160","author":"Weger","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0060","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","article-title":"Serious infection following anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Lessons from interpreting data from observational studies","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0065","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0075","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0080","first-page":"118","article-title":"Reactivation of herpes viruses (HHV-1\u00a0and HHV-3) infections are increased in RA patients treated with adalimumab or infliximab","volume":"66","author":"Strangfeld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jbspin.2007.10.001","article-title":"Recommendations of the french society for rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis","volume":"74","author":"Fautrel","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0090","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate to severe Crohn's disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0100","series-title":"Mises \u00e0 jour en gyn\u00e9cologie et obst\u00e9trique CNGOF","article-title":"Maladies inflammatoires chroniques intestinales et grossesse","author":"Ducarme","year":"2010"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0105","first-page":"67","article-title":"How to improve the safety of biologic therapy in Crohn's disease","volume":"60","author":"Ferkolj","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0110","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy analyses from a large US observational study","volume":"9","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2009.117762","article-title":"Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry","volume":"69","author":"Mariette","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jbspin.2010.02.002","article-title":"Lymphoma, rheumatoid arthritis, and TNF\u03b1 antagonists","volume":"77","author":"Mariette","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0897.1999.tb00110.x","article-title":"Immunodiagnostic evaluation in women with reproductive failure","volume":"42","author":"Kaider","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/humrep\/dep011","article-title":"Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF","volume":"34","author":"Boomsma","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.8755-8920.2003.00132.x","article-title":"Should we re-examine the status of lymphocyte alloimmunization therapy for recurrent spontaneous abortion?","volume":"50","author":"Chaouat","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0897.2008.00580.x","article-title":"Immunological factors in pregnancy wastage: fact or fiction","volume":"59","author":"Clark","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0897.2008.00680.x","article-title":"Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion?","volume":"61","author":"Clark","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1\u00a0cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.fertnstert.2007.02.012","article-title":"Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failure","volume":"89","author":"Fukui","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0160","first-page":"33","article-title":"Anti-TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2","volume":"204","author":"Nadkarni","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-0897.2008.00596.x","article-title":"Clinical implication of natural killer cells and reproduction","volume":"59","author":"Kwak-Kim","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0170","first-page":"1897","article-title":"The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: it's time to get serious","volume":"30","author":"Wallace","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0897.2010.00826.x","article-title":"First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - Case report","volume":"64","author":"Jerzak","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0180","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.lpm.2008.05.017","article-title":"Immunosuppresseurs utilis\u00e9s dans les maladies syst\u00e9miques\u00a0: que faire en cas de grossesse\u00a0?","volume":"37","author":"Elefant","year":"2008","journal-title":"Presse Med"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0185","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0190","first-page":"33","article-title":"High serum levels of infliximab detected in the newborn of a mother receiving during pregnancy","volume":"128","author":"Vasiliauskas","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/138920111795470903","article-title":"Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease","volume":"12","author":"Chaparro","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0200","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2005.02405.x","article-title":"Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease","volume":"21","author":"Mahadevan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","article-title":"Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding","volume":"16","author":"Gisbert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.gtc.2009.07.006","article-title":"Pregnancy and inflammatory bowel disease","volume":"38","author":"Mahadevan","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0220","first-page":"33","article-title":"The use of biologic therapy in the pregnant patient","volume":"63","author":"Mahadevan","year":"2010","journal-title":"Pract Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ajg.2010.464","article-title":"The London position statement of the World Congress of Gastroenterology on biological therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics","volume":"106","author":"Mahadevan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0230","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2036.2009.4097.x","article-title":"Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey","volume":"30","author":"Oussalah","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0235","first-page":"A54","article-title":"Safety of infliximab in Crohn's disease: data from the 5000 - Patient TREAT registry","volume":"126","author":"Lichtenstein","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0240","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0245","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0250","first-page":"A144","article-title":"Infliximab levels in infants born to women with inflammatory bowel disease","volume":"132","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0255","first-page":"258","article-title":"Infliximab levels in breast-milk of a nursing Crohn's patient","volume":"96","author":"Peltier","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MCG.0b013e31817f9367","article-title":"Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery","volume":"43","author":"Kane","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0265","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s10620-006-9452-2","article-title":"The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy","volume":"51","author":"Coburn","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0270","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00054725-200608000-00020","article-title":"Successful use of adalimumab (Humira) for Crohn's disease in pregnancy","volume":"12","author":"Mishkin","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0275","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/gut.2005.065417","article-title":"Adalimumab use in pregnancy","volume":"54","author":"Vesga","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0280","first-page":"738","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy","volume":"25","author":"Schnitzler","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0285","article-title":"Pregnancy during adalimumab use for psoriasis","author":"Dessinioti","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0290","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21198","article-title":"Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature","volume":"16","author":"J\u00fcrgens","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0295","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/gut.2008.166884","article-title":"Certolizumab use in pregnancy","volume":"58","author":"Oussalah","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0300","doi-asserted-by":"crossref","first-page":"A146","DOI":"10.1016\/S0016-5085(09)60658-2","article-title":"Certolizumab use in pregnancy: low levels detected in cord blood","volume":"136","author":"Mahadevan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0305","first-page":"A8","article-title":"Placental transfer of the anti-TNF antibody TN3\u00a0in rats: comparison of immunoglobulin G1\u00a0and pegylated Fab versions","volume":"55","author":"Stephens","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0310","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfr083","article-title":"The use of surrogate antibodies to evaluate the developmental and reproductive toxicity (DART) potential of an anti-TNF\u03b1 PEGylated Fab\u2019 monoclonal antibody","author":"Wakefield","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0315","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the food and drug administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0320","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/kel400","article-title":"Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy","volume":"46","author":"Roux","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0325","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0961203306070970","article-title":"Efficacy and safety of etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy","volume":"15","author":"Micheloud","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0897.2001.d01-25.x","article-title":"Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis","volume":"46","author":"Sills","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0335","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2169\/internalmedicine.49.2439","article-title":"A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment","volume":"49","author":"Umeda","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0345","first-page":"93","article-title":"Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis","volume":"29","author":"Scioscia","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jgyn.2011.05.009_bib0350","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3899\/jrheum.100077","article-title":"Measuring multiple etanercept levels in the breast milk of a nursing mother with rheumatoid arthritis","volume":"37","author":"Keeling","year":"2010","journal-title":"J Rheumatol"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231511001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231511001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:27:20Z","timestamp":1712586440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231511001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0368231511001591"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2011.05.009","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}